--- title: Buy Eflornithine 13.9% Cream Tube Online description: Eflornithine 13.9% cream is a topical prescription treatment used to reduce unwanted facial hair in women. Order this effective solution from our secure online pharmacy for reliable delivery. type: product language: en url: https://liabilis.com/order-eflornithine-online-en.html availability: in_stock shipping: - type: Standard Airmail price: 10.00 currency: USD area: Worldwide time: 14-21 days - type: Tracked Express price: 30.00 currency: USD area: Worldwide tracking: true time: 5-9 days price_min: 74.09 price_max: 173.99 currency: USD offers: - name: 13.9% x 1 tube price: 74.09 - name: 13.9% x 2 tubes price: 126.34 - name: 13.9% x 3 tubes price: 173.99 --- # Buy Eflornithine 13.9% Cream Tube Online Eflornithine is a topical cream that works as an enzyme inhibitor to slow the growth of unwanted facial hair in women. It is a prescription treatment applied directly to the skin, designed for those seeking a pharmacological approach to manage hirsutism. Our online pharmacy provides a trusted source for obtaining Eflornithine in a 13.9% cream tube formulation. ## Pricing and Options | Dosage | Pack Size | Price (USD) | Price Per Pill | Status | | :--- | :--- | :--- | :--- | :--- | | **13.9%** | 1 tube | **$74.09** | $74.09 | In Stock | | **13.9%** | 2 tubes | **$126.34** | $63.17 | In Stock | | **13.9%** | 3 tubes | **$173.99** | $58.00 | In Stock | [Buy Now](https://liabilis.com/order-eflornithine-online-en.html) ## Introduction Eflornithine is a topical medication formulated as a 13.9 % solution in a tube. It belongs to the class of ornithine decarboxylase (ODC) inhibitors and is primarily approved for the reduction of unwanted facial hair growth in adult women. The active ingredient is the same chemical compound found in the branded product Vaniqa. By interfering with hair-follicle biochemistry, Eflornithine slows the rate of hair emergence, providing a non-laser, reversible option for managing facial hirsutism. --- ## Quick Reference Facts **Active Ingredient** : Eflornithine **Form** : tube 13.9 % solution **Primary Uses** : - Reduction of unwanted facial hair in adult women (facial hirsutism) --- ## What is Eflornithine? Eflornithine is the generic version of medications containing the active compound Eflornithine. It is marketed as a clear, viscous solution that patients apply to the skin once daily. The drug is classified as an ODC inhibitor, a pharmacologic class that targets polyamine synthesis within hair follicles. The original branded formulation, Vaniqa, received regulatory approval in the United States (FDA) and European Union (EMA) for facial hair reduction. Generic equivalents such as this tube-packaged solution provide the same therapeutic effect at a lower cost, and they are considered bio-equivalent to the brand name product. --- ## How Eflornithine Works Eflornithine exerts its effect by irreversibly binding to the enzyme ornithine decarboxylase, which catalyzes the conversion of ornithine to putrescine-a key polyamine required for cell proliferation. In hair follicles, polyamines support the rapid division of matrix cells that generate the hair shaft. By inhibiting ODC, Eflornithine reduces intracellular polyamine concentrations, slowing the anagen (growth) phase and consequently decreasing the emergence of new hairs. The onset of visible hair-growth reduction typically occurs after 4-8 weeks of consistent daily use. Because the drug acts locally with minimal systemic absorption, the duration of action is limited to the period of application; hair growth resumes at its usual rate once treatment is discontinued. Eflornithine is metabolized primarily within the epidermis, and any absorbed fraction is eliminated renally without significant accumulation. --- ## Conditions Treated with Eflornithine - **Facial hirsutism in adult women** - The FDA-approved indication. By slowing follicular proliferation, the solution reduces the number of visible hairs, offering a non-invasive alternative to laser or electrolysis. - **Unwanted facial hair associated with hormonal imbalances** - When hirsutism stems from conditions such as polycystic ovary syndrome, Eflornithine can be used adjunctively to lessen cosmetic concerns while underlying endocrine therapy is pursued. - **Post-treatment maintenance after laser therapy** - Some clinicians recommend continued topical Eflornithine to prolong the results of laser hair removal, as the medication helps maintain a lower hair-growth rate. --- ## Is Eflornithine the Right Medication for You? Eflornithine is most appropriate for adult women who desire a reversible, topical method to lessen facial hair density. Ideal candidates are those with mild to moderate hirsutism who prefer to avoid permanent procedures. The medication is especially useful when the skin is intact and free of active dermatologic conditions, allowing optimal absorption. Contraindications include known hypersensitivity to Eflornithine or any excipients in the formulation, and use on compromised skin (e.g., eczema, open wounds) because irritation may be amplified. Pregnant or breastfeeding women should consult a healthcare professional, as safety data are limited. Individuals with severe, treatment-resistant hirsutism may require additional or alternative therapies. --- ## Buying Eflornithine from [our online pharmacy](https://liabilis.com/order-eflornithine-online-en.html) ### Why Choose Our Service? Accessing a cost-effective, high-quality generic product can be challenging through conventional retail pharmacies. [our online pharmacy](https://liabilis.com/order-eflornithine-online-en.html) bridges that gap by offering Eflornithine at pricing close to the manufacturer’s cost, helping patients who seek an affordable alternative to branded options. ### Quality & Safety Assurance We partner with licensed international pharmacies to ensure quality and authenticity. Every tube of Eflornithine is sourced from certified manufacturers that comply with Good Manufacturing Practice (GMP) standards, and each shipment undergoes strict verification before dispatch. ### Pricing & Access Because this is a generic formulation, the price is substantially lower than the brand-name Vaniqa, while delivering identical therapeutic performance. Our pharmacy service makes the medication available to customers worldwide, regardless of local stock limitations or insurance coverage constraints. ### Discreet Delivery Privacy is paramount. Orders are packaged in unbranded, tamper-evident envelopes and shipped via express delivery that typically arrives within 7 days, or standard airmail in approximately three weeks. All personal information is handled in compliance with data-protection regulations. --- ## Use: Dosing, Missed Dose, Overdose - **Standard dosing** - Apply a thin, even layer of the 13.9 % solution to clean, dry facial skin once each evening. Do not exceed the recommended amount; additional applications do not increase efficacy and may heighten irritation. - **Missed dose** - If a dose is forgotten, apply it as soon as you remember provided it is still the same day. If the scheduled time for the next dose is near, skip the missed application and resume the regular nightly routine. - **Suspected overdose** - Systemic toxicity from topical Eflornithine is rare. In the unlikely event of excessive application (e.g., multiple tubes applied at once), rinse the area with mild soap and water, and seek medical advice if irritation persists or systemic symptoms such as dizziness develop. - **Precautions** - Avoid simultaneous use of other topical irritants (e.g., retinoids, benzoyl peroxide) unless directed by a clinician. Do not apply to broken or inflamed skin. Alcohol consumption does not affect topical efficacy, but operating heavy machinery is discouraged if significant skin irritation causes discomfort. --- ## Safety Information ### ⚠️ Who Should Not Take Eflornithine - Individuals with a documented allergy to Eflornithine or any component of the vehicle (e.g., preservatives). - Patients with active dermatitis, open wounds, or infections on the face where the product would be applied. - Women who are pregnant or breastfeeding without prior medical consultation, due to insufficient safety data. ### Common Side Effects - **Localized skin irritation** - mild erythema, tingling, or burning sensations occurring in 10-20 % of users; usually transient and can be reduced by applying a moisturizer after the solution dries. - **Dryness or flaking** - may develop with prolonged use; skin moisturizers can alleviate discomfort. ### Serious Side Effects (Seek Immediate Medical Help) - **Severe allergic reaction** - symptoms such as swelling of the face, lips, tongue, or throat, hives, or difficulty breathing warrant urgent care. - **Contact dermatitis** - persistent, intense redness, blistering, or oozing may indicate a hypersensitivity reaction requiring discontinuation and medical evaluation. ### Drug & Food Interactions - **Topical co-applications** - concurrent use of strong keratolytic agents (e.g., high-strength salicylic acid) may increase skin absorption and irritation; stagger applications or avoid combined use. - **Systemic medications** - because systemic exposure is minimal, clinically significant interactions are unlikely, but patients on oral chemotherapy or immunosuppressants should discuss usage with their provider. --- ## Off-Label and Investigational Uses of Eflornithine - **Treatment of other hypertrichosis conditions** - Small case series have explored topical Eflornithine for excessive hair growth on the arms and chest, noting modest reductions. These uses remain off-label and should be undertaken only under specialist supervision. - **Adjunct in cutaneous leishmaniasis** - While systemic Eflornithine is established for African trypanosomiasis, limited research has examined topical application for skin-borne parasitic infections. Evidence is preliminary, and regulatory approval for this indication does not exist. Patients considering any off-label use must obtain explicit guidance from a qualified healthcare professional, as safety and efficacy have not been formally validated by regulatory agencies. --- ## Storage & Handling - Store the tube at room temperature (15-25 °C). - Keep the container tightly closed and protect from direct sunlight or excessive heat, which can degrade the active compound. - Do not use the product beyond the expiration date printed on the label. - Dispose of the empty tube in accordance with local regulations for pharmaceutical waste; do not flush large quantities down the drain. --- ## Frequently Asked Questions **Practical Use & Lifestyle** - **Can I apply Eflornithine on a humid beach day?** Yes, the solution can be used in humid conditions, but ensure the skin is dry before application. Excess moisture may dilute the film and reduce absorption. - **How should I travel with my tube of Eflornithine?** Pack the sealed tube in a carry-on bag, protecting it from extreme temperatures. The product tolerates normal cabin temperatures but should not be left in a hot car trunk for extended periods. - **Will sunscreen affect the efficacy of Eflornithine?** Applying sunscreen after the solution has dried (approximately 5-10 minutes) does not interfere with its action and is recommended to protect sun-sensitive skin. **Product & Formulation Details** - **What does the Eflornithine tube look like?** The tube is a white, opaque plastic container with a flip-top cap. The solution appears clear, slightly viscous, and is labeled with a 13.9 % concentration. - **Are there any inactive ingredients I should be aware of?** The formulation contains water, ethanol, and a small amount of a stabilizing preservative. Patients with known sensitivities to ethanol or preservatives should verify component lists before use. **Regulatory & Safety Nuances** - **Is Eflornithine considered a controlled substance?** No, topical Eflornithine is not scheduled or controlled; it is available by prescription in most jurisdictions due to its therapeutic classification. - **Can Eflornithine be detected in standard drug tests?** Because systemic absorption is negligible, Eflornithine does not appear in routine urine or blood drug screenings. **Scientific & Clinical Curiosity** - **When was Eflornithine first approved for facial hair reduction?** The branded product Vaniqa received FDA approval in 200, and the generic formulation followed shortly thereafter after patent expiration. - **How does Eflornithine compare to laser hair removal?** Eflornithine provides a reversible, gradual reduction in hair density, whereas laser therapy offers permanent follicular destruction. The two methods can be complementary, with Eflornithine used for maintenance after laser treatment. --- ## Glossary **Ornithine Decarboxylase (ODC)** : An enzyme that catalyzes the first step in polyamine synthesis, essential for cell growth and hair-follicle proliferation. **Polyamines** : Small organic cations (e.g., putrescine, spermidine) that support DNA stabilization and cell division; reduced levels slow hair growth. **Anagen Phase** : The active growth phase of the hair cycle during which hair shafts are produced. **Bioequivalence** : The condition where two pharmaceutical products release the same amount of active ingredient into the bloodstream at the same rate and extent. --- ## Disclaimer The information provided about **Eflornithine** is intended for general educational purposes and does not substitute professional medical consultation. All therapeutic decisions, including those concerning off-label applications, should be made under the guidance of a qualified healthcare provider. Readers are presumed to be responsible adults capable of making informed health choices. Our pharmacy service offers access to **Eflornithine** for individuals encountering limited availability through conventional channels or seeking affordable generic alternatives. Always discuss with your doctor before initiating, adjusting, or discontinuing any medication.